Literature DB >> 18089386

Mesenchymal stem cells contribute to insulin-producing cells upon microenvironmental manipulation in vitro.

C Chang1, D Niu, H Zhou, F Li, F Gong.   

Abstract

BACKGROUND: Extracellular microenvironment and intrinsic genetic programs determine the fate of stem cells. We observed whether mesenchymal stem cells (MSCs) contributed to insulin-producing cells in a manipulated microenvironment.
METHODS: We delivered pancreatic pieces into Niobium-Coated Dynamatrix to construct a simulated pancreatic microenvironment, upon which soluble cytokine exchange and direct cell-cell contact between MSCs and pancreatic cells could occur. Bone marrow-derived MSCs were cultured upon the microenvironment. Differentiated isletlike cells were observed under an inverted microscope. Insulin in supernates was measurement by enzyme-linked immunosorbent assay. Insulin and c-peptide expression were verified by fluorescent immunocytochemistry and fluorescence in situ hybridization. Apoptosis of isletlike masses in high-glucose DMEM was detected by FACS.
RESULTS: After 3 to 4 weeks in culture, typical isletlike masses were observed. Insulin secreted by differentiated cells (414.47+/-30.30 mIU/L) was much greater than that of undifferentiated cells (4.89+/-1.01 mIU/L; P<.05). Insulin and c-peptide expression were positive both in protein and mRNA levels. The transdifferentiated isletlike mass did not undergo apoptosis after another 3 weeks of culture in high-glucose DMEM.
CONCLUSION: This simulated injury microenvironment without induction guided MSCs to functional isletlike cells hopefully to replace beta cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18089386     DOI: 10.1016/j.transproceed.2007.09.026

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

Review 1.  Stem cell-derived islet cells for transplantation.

Authors:  Juan Domínguez-Bendala; Luca Inverardi; Camillo Ricordi
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

2.  Mesenchymal stem cells derived from bone marrow of diabetic patients portrait unique markers influenced by the diabetic microenvironment.

Authors:  Smruti M Phadnis; Surendra M Ghaskadbi; Anandwardhan A Hardikar; Ramesh R Bhonde
Journal:  Rev Diabet Stud       Date:  2009-12-30

3.  Role of injured pancreatic extract promotes bone marrow-derived mesenchymal stem cells efficiently differentiate into insulin-producing cells.

Authors:  Hongbin Xie; Yunshuai Wang; Hui Zhang; Hui Qi; Hanxin Zhou; Fu-Rong Li
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 4.  Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus.

Authors:  Seyed Jafar Hashemian; Marjan Kouhnavard; Ensieh Nasli-Esfahani
Journal:  J Diabetes Res       Date:  2015-10-20       Impact factor: 4.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.